Pricing Log in Create free account
Saturday 17 October 2026 Export PRVA’s income statement to Excel — free account

Privia Health Group, Inc.

PRVA Healthcare Health Information Services

Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024. In the quarter to June 2026, revenue grew 21.4%, EPS grew 250.0% and free cash flow fell 86.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

22.46 0.16 −0.71%
Market cap
$2.9B
P/E
102×
Fwd P/E
87.8×
Dividend yield
—
F-score
6/9
Altman Z
4.78
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 22.24
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — 2 — 2 8 1 4 3 4 — — —
Insider Ownership 5.92%

Capital & Financial Ratios $m

Market Cap 2,890.00
Revenue 2,358.07
Net Income 33.84
Free Cash Flow 131.13
Net Debt (412.20)
Current Ratio 1.62 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 102.09 (above 35: high)
Fwd P/E 87.80 (above 35: high)
P/S ratio 1.20
P/B ratio 3.38
Past 5Y EPS Growth (10.99%) (below 0%: weak)
This Y EPS Growth 43.08% (at or above 15%: strong)
Next Y EPS Growth 61.99% (at or above 15%: strong)
Next Y revenue growth 15.79% (at or above 10%: strong)
Next 5Y EPS Growth 46.98% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.0×, against a ten-year median of 1.4×; over the ten years it ranged from 0.9× in 2026 to 5.0× in 2021.
P/E against its own 10 years 21.52%
10-year low 10-year high
P/S against its own 10 years 6.25%
10-year low 10-year high
P/B against its own 10 years 12.07%
10-year low 10-year high
EV/Sales against its own 10 years 9.96%
10-year low 10-year high
EV/FCF against its own 10 years 14.25%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2018 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 390 491 480 412
Receivables 291 316 401 574
Inventory — — — —
Other — — — —
701 835 911 1,025
2023 2024 2025 Q'26
Payables 58 82 97 91
ST’ Debt — — — —
Other 326 365 470 541
387 449 569 634

Compound Annual Growth %

10y 5y 3y
Sales — 21.04% 16.10%
Cash Flow — 33.25% 51.28%
Earnings — (6.01%) 0.00%
Book Value — 40.66% 15.07%

Revenue $m

Mar Jun Sep Dec Year
’26 604 633 — — —
’25 480 521 580 541 2,123
’24 415 422 438 461 1,736
’23 386 413 417 441 1,658
’22 314 336 343 364 1,357
’21 214 226 252 275 966
’20 213 183 207 214 817
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (49) 1 — — —
’25 (24) 8 52 128 163
’24 (33) 34 33 75 109
’23 (13) 8 22 64 81
’22 (5) 7 16 29 47
’21 (2) 7 63 (12) 55
’20 (7) 14 36 (3) 39
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (49) 1 — — —
’25 (24) 8 52 128 163
’24 (33) 34 33 75 109
’23 (13) 8 22 64 81
’22 (5) 7 16 29 47
’21 (2) 7 62 (12) 55
’20 (7) 13 36 (3) 39
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.02 0.07 — — —
’25 0.03 0.02 0.05 0.07 0.18
’24 0.02 0.03 0.03 0.03 0.11
’23 0.06 0.06 0.05 0.02 0.19
’22 (0.16) (0.10) 0.01 0.14 (0.08)
’21 0.06 (1.68) (0.09) (0.11) (1.83)
’20 0.06 0.05 0.17 0.04 0.32
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — 20.20 17.99 19.68 15.92 18.77

Analyst estimates 2026–2028

Powerpack
High — — — — — 50.77 44.64 30.15 24.05 26.51
People
People Employees — — — — 559 810 964 1,102 1,140 1,226
Revenue/emp, $m — — 0.00 0.00 1.46 1.19 1.41 1.50 1.52 1.73
Income, $m
Income, $m Revenue — — 658 786 817 966 1,357 1,658 1,736 2,123
Gross margin, % — — 8.36 8.71 10.11 6.59 9.93 9.74 10.19 9.87
EBT — — (4) 9 23 (219) (19) 29 28 44
EBT margin, % — — (0.61) 1.16 2.87 (22.61) (1.37) 1.75 1.61 2.07
Net income — 0 (3) 8 31 (191) (12) 21 17 30
Depreciation — — 1 2 2 3 5 7 7 10
Per share, $
Per share, $ Revenue — — 6.21 8.20 8.52 9.39 12.26 14.20 14.54 17.38
Earnings — — (0.03) 0.08 0.32 (1.83) (0.08) 0.20 0.12 0.19
Cash flow — — 0.05 0.25 0.41 0.53 0.43 0.69 0.92 1.34
Capex — — 0.00 (0.06) 0.00 (0.01) 0.00 0.00 0.00 0.00
Free cash flow — — 0.05 0.19 0.40 0.53 0.43 0.69 0.92 1.34
Book value — — 0.00 0.00 1.50 4.37 4.69 5.20 5.72 6.47
Shares, m — — 106 96 96 103 111 117 119 122
Valuation, ×
Valuation, × P/E — — 70.42 70.42 70.42 0.00 0.00 124.79 150.38 131.72
P/S — — 2.70 2.70 2.70 2.76 1.82 1.67 1.34 1.36
P/B — — 14.78 14.78 14.78 5.92 4.75 4.56 3.42 3.66
EV/Sales — — 2.64 2.64 2.64 2.46 1.59 1.45 1.08 1.15
EV/FCF — — 50.05 50.05 50.05 43.56 45.67 29.94 17.20 15.01
Cash, $m
Cash, $m Operating cash flow — — 5 24 39 55 47 81 109 163
Capex — — 0 (6) 0 (1) 0 0 — —
Free cash flow — — 5 19 39 55 47 81 109 163
Balance, $m
Balance, $m Working capital — — — 14 43 256 288 314 386 342
Total debt — — — 40 33 32 8 — — —
Net debt — — — (7) (52) (289) (348) (390) (491) (480)
Shareholders’ equity — — — — 144 450 519 607 683 791
Returns, %
Returns, % ROA — — 0.00 0.00 19.00 (37.08) (1.16) 2.57 1.35 1.83
ROIC — — — 0.00 17.28 (84.26) (6.99) 5.92 5.52 6.87
ROE — — 0.00 6.42 24.61 (63.39) (1.77) 4.10 2.23 3.11
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Privia Health Group, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
DOCS Doximity, Inc. $5.6B 34.8× 26.2× +7.34% (above 0%: growing) −53.57% (below 0%: shrinking) −34.14% (below 0%: shrinking) 84.87% 21.48% Compare
WAY Waystar Holding Corp. $5.4B 38.0× 22.4× +18.11% (above 0%: growing) +10.53% (above 0%: growing) −52.42% (below 0%: shrinking) 69.44% 23.79% Compare
HTFL Heartflow, Inc. $4.4B — (loss-making) — (loss-making) +47.57% (above 0%: growing) n/m +62.62% (above 0%: growing) 83.00% (27.93%) Compare
PRVA Privia Health Group, Inc. $2.9B 102× 87.8× +21.39% (above 0%: growing) +250.00% (above 0%: growing) −86.20% (below 0%: shrinking) 9.93% 1.86%
SDGR Schrodinger, Inc. $1.9B — (loss-making) — (loss-making) +7.54% (above 0%: growing) n/m +34.43% (above 0%: growing) 55.07% (70.55%) Compare
OMCL Omnicell, Inc. $1.6B 41.6× 55.1× +7.45% (above 0%: growing) +341.67% (above 0%: growing) +107.90% (above 0%: growing) 48.98% 10.39% Compare
CERT Certara, Inc. $1.5B — (loss-making) — (loss-making) +0.99% (above 0%: growing) n/m −78.46% (below 0%: shrinking) 62.34% (0.21%) Compare
GDRX GoodRx Holdings, Inc. $1.2B 62.7× 30.9× −1.31% (below 0%: shrinking) −25.00% (below 0%: shrinking) +112.45% (above 0%: growing) 89.52% 11.79% Compare
OMDA Omada Health, Inc. $1.1B 252× 143× +43.12% (above 0%: growing) n/m +45.71% (above 0%: growing) 72.62% 4.04% Compare
Median of peers $1.8B 41.6× 30.9× +7.49% −7.23% +40.07% 71.03% 7.22%

All 51 Health Information Services stocks →

Privia Health Group, Inc. (PRVA) key facts

  • Strength: Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
  • Strength: Net income was $29.7 million, or $0.19 per share (basic), a net margin of 1.08%.
  • Privia Health Group, Inc. (PRVA) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, PRVA traded at $22.46, a market capitalization of $2.9 billion.
  • At that price the stock trades at 102× trailing-twelve-month earnings and 1.2× sales; its P/E is higher than 22% of its own readings over the past ten years.
  • Return on equity was 3.11% and debt-to-equity 0.00.
  • Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 4.78 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Privia Health Group, Inc. (PRVA) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/PRVA · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com